Deborah H. Charych - Mar 1, 2023 Form 3/A - Amendment Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
3/A - Amendment
Date filed
3/3/2023, 11:05 AM
Date Of Original Report
Feb 16, 2023
Previous filing
Feb 16, 2023
Next filing
Aug 29, 2023

No securities are beneficially owned.

Remarks:

(1) Dr. Charych's appointment to the Board of Directors (the "Board") of Skye Bioscience, Inc. was approved by the Board on February 14, 2023, however such appointment was not effective until March 1, 2023. Accordingly, this Form 3/A is being filed to reflect the effective date of her appointment. (2) Exhibit 24 - Power of Attorney (previously filed).